Schedule 13G ownership disclosure

CytomX Therapeutics Inc

Security class unavailable · CUSIP: 23284F105

Event date: 2015-10-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,017,604
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-15-000043
Form type
SC 13G
Filer
CytomX Therapeutics, Inc.
CIK
CIK 1501989
Filed
Oct 21, 2015
Reporting period
Oct 14, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub